Article
The Current Status of Comprehensive Genomic Profiling in the Management of Metastatic Castration-Resistant Prostate Cancer: A Study from a Cooperative Hospital for Cancer Genomic Medicine in Japan.
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi - 1 Jan 2024
Akatsuka Jun, Kimura Go, Takadate Mami, Hiraoka Sayuri, Sahara Tomoko, Iwai Takuma, Hasegawa Hiroya, Mikami Hikaru, Obayashi Kotaro, Takeda Hayato, Endo Yuki, Toyama Yuka, Yamamoto Yoichiro, Yamada Takeshi, Kondo Yukihiro
Abstract excerpt
BACKGROUND: Several effective treatment modalities against metastatic castration-resistant prostate cancer (mCRPC) are available; however, an unmet clinical need persists for mCRPC treatment because resistance to these therapies is inevitable. This study aimed to evaluate the status of comprehensive genomic profiling (CGP) and its impact on subsequent treatments for patients with mCRPC at our hospital. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.